Clinical Trial

The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy

Study acronym: BABY DUCHENNE
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the BABY DUCHENNE study is to evaluate the natural history and characterize the early clinical outcomes in very young children (0-3 years) with Duchenne muscular dystrophy (DMD) identified by newborn screening programs.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-22; most recent amendment 2026-04-27.
Status change: Not Yet Recruiting → Recruiting 2026-04-27
Trial Details
NCT Number NCT07092540
Lead Sponsor University of Rochester
Collaborators: United States Department of Defense
Conditions Duchenne Muscular Dystrophy (DMD)
Enrollment 105 participants
Start Date 2026-05-30
Primary Completion 2029-08-31 (estimated)
Study Completion 2029-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-04